Abstract
Multiple myeloma is the most common primary bone malignancy. The overall 5-year survival is poor, despite current therapeutic options. FDG PET/MR imaging can aid to detect early bone involvement, differentiate precursor lesions from myeloma, better define lytic lesions, detect extramedullary disease, predict prognosis, and assess response to treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM. MR imaging and PET/CT in diagnosis and management of multiple myeloma. Radiographics. 2015;35(2):438–54.
Hanrahan CJ, Christensen CR, Crim JR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics. 2010;30(1):127–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Gupta, R. (2018). Multiple Myeloma. In: PET/MR Imaging . Springer, Cham. https://doi.org/10.1007/978-3-319-65106-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-65106-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65105-7
Online ISBN: 978-3-319-65106-4
eBook Packages: MedicineMedicine (R0)